Bratton Capital Management, L.P. is an investment fund managing more than $1.5 billion ran by John Cochran. There is currently 1 company in Mr. Cochran’s portfolio. The largest and only investment include Aquestive Therapeutics Inc worth $1.5 billion.
As of 7th November 2023, Bratton Capital Management, L.P.’s top holding is 9,810,958 shares of Aquestive Therapeutics Inc currently worth over $1.5 billion and making up 100.0% of the portfolio value.
Relative to the number of outstanding shares of Aquestive Therapeutics Inc, Bratton Capital Management, L.P. owns more than 0.1% of the company.
Currently, Bratton Capital Management, L.P.'s portfolio is worth at least $1.5 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Bratton Capital Management, L.P. office and employees reside in Fort Worth, Texas. According to the last 13-F report filed with the SEC, John Cochran serves as the Vice President at Bratton Capital Management, L.P..
The two most similar investment funds to Bratton Capital Management, L.P. are Glg Partners L.P. and Zeke Capital Advisors. They manage $1.5 billion and $1.5 billion respectively.
Bratton Capital Management, L.P.’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
100% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $36.3 million.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Aquestive Therapeutics Inc |
No change
9,810,958
|
$1,501,766,000 | 100.00% |
| No transactions found | |||
| Showing first 500 out of 1 holdings | |||